1 active not recruiting, 1 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Unknown 1 |
| Phase 2 | 2 | Active not recruiting 1, Unknown 1 |
Follow Diane George: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant CliniMACS CD34+ Reagent System, Thiotepa, Cyclophosphamide - Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML) | Phase 1 / Phase 2 | Unknown | Diane George | 14 | 2013-06-03 | 2024-06-04 |
| CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation CD34 Stem Cell Selection Therapy - Bone Marrow Failure Syndrome, Severe Aplastic Anemia | Phase 1 / Phase 2 | Active not recruiting | Diane George | 37 | 2013-03-01 | 2025-08-14 |
Acquired Immunodeficiency Syndrome (2) · Anemia, Aplastic (2) · Anemia, Diamond-Blackfan (2) · Anemia, Sickle Cell (2) · Bone Marrow Failure Disorders (2) · Hemoglobinopathies (2) · Histiocytosis (2) · Histiocytosis, Langerhans-Cell (2) · Lymphohistiocytosis, Hemophagocytic (2) · Macrophage Activation Syndrome (2) · Neutropenia, Severe Congenital, Autosomal Recessive 3 (2) · Primary Immunodeficiency Diseases (2) · Shwachman-Diamond Syndrome (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1)
Alemtuzumab (1) · Busulfan (1) · Cyclophosphamide (1) · Melphalan (1) · Methylprednisolone (1) · Methylprednisolone Hemisuccinate (1) · Tacrolimus (1) · Thiotepa (1) · fludarabine (1) · fludarabine phosphate (1)
United States (2)